Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
3.250
-0.060 (-1.81%)
Jun 11, 2026, 3:00 PM CST
SHA:600594 Market Cap
SHA:600594 has a market cap or net worth of 2.6 billion as of June 11, 2026. Its market cap has decreased by -10.54% in one year.
Market Cap
2.60B
Enterprise Value
2.90B
Revenue
1.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
3.25
Market Cap Chart
Since March 23, 2004, SHA:600594's market cap has increased from 1.79B to 2.60B, an increase of 45.30%. That is a compound annual growth rate of 1.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 2.60B | -16.83% |
| Dec 31, 2025 | 3.12B | 11.44% |
| Dec 31, 2024 | 2.80B | -37.83% |
| Dec 29, 2023 | 4.51B | 2.89% |
| Dec 30, 2022 | 4.38B | -31.98% |
| Dec 31, 2021 | 6.44B | 55.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet AIM Pharm. | 2.88B |
| Jiangxi Synergy Pharmaceutical | 2.83B |
| Anhui Sunhere Pharmaceutical Excipients | 2.81B |
| Honz Pharmaceutical | 2.80B |
| Baotou Dongbao Bio-Tech Co.,Ltd | 2.76B |
| Tuoxin Pharmaceutical Group | 2.74B |
| Hainan Huluwa Pharmaceutical Group | 2.58B |
| Anhui Fengyuan Pharmaceutical | 2.55B |